Otonomy Income Statement 2021-2011 | OTIC

Brief overview of financial performance at Otonomy

The overview follows changes across a five-year period. Revenue reported by Otonomy was 683 thousand dollars at the beginning of the period and 125 thousand dollars at the end. The cumulative result was −81.7%, corresponding to roughly −28.8% per year. Sales followed a declining trajectory over the five years.

The gross result shifted from −981 thousand dollars to −245 thousand dollars, or +75%. The relationship between revenue and direct costs remained stable. Comparing the endpoints gives gross margins of −143.6% and −196%. Weakening gross profitability reduces the quality of the top-line trend.

Over the period, EBITDA shifted from −$111 million to −$48.8 million, a change of +56%. Additional revenue translated efficiently into EBITDA. EBITDA margin was −16218.6% at the start and −39015.2% at the end. Cost pressure reduced operating profitability.

The final result was −$111 million initially and −$51.2 million in the final year. The negative result improved without reaching break-even.

The market value of the business moved from $439 million to $128 million, or −70.9%. Investors remain cautious despite better financial results.

Summary assessment

Signs of deterioration dominate the five-year picture. The positive side is supported by net-income growth. The main areas of concern are lower investor confidence, a lower gross margin and a narrow EBITDA buffer. The next reporting periods will show whether revenue, margins, and final profitability can strengthen.